Literature DB >> 20419384

Significant association of high-risk human papillomavirus (HPV) but not of p53 polymorphisms with oral squamous cell carcinomas in Malaysia.

Rajan Saini1, Thean-Hock Tang, Rosnah Binti Zain, Sok Ching Cheong, Kamarul Imran Musa, Deepti Saini, Abdul Rashid Ismail, Mannil Thomas Abraham, Wan Mahadzir Wan Mustafa, Jacinta Santhanam.   

Abstract

PURPOSE: The purpose of this study was to evaluate the role of HPV and p53 polymorphisms in oral squamous cell carcinomas (OSCC) affecting Malaysian population.
METHODS: We analysed frozen samples from 105 OSCC as well as 105 oral specimens derived from healthy individuals. PCR assays targeting two regions of the virus were used. PCR amplification for the analysis of p53 codon 72 arginine/proline alleles was carried out in a separate reaction.
RESULTS: HPV DNA was detected in 51.4% OSCC samples, while 24.8% controls were found to be HPV positive. HPV was found to be significantly associated with OSCC (P < 0.001, OR = 4.3 after adjustment for habits) when compared to controls. High-risk HPV was found to be significantly associated with OSCC cases (P < 0.05). Demographic profiles of age, gender, race and habits were not associated with HPV presence in cases and controls. However, significantly less HPV positivity was seen in poorly differentiated compared to well-differentiated OSCCs. No significant association was found between HPV positivity and p53 polymorphisms in cases and control groups. Additionally, we found no association of codon 72 polymorphism with oral cancer.
CONCLUSIONS: This study indicates that high-risk HPV infection is one of the contributing factors for OSCCs. HPV 16 was the predominant type found in Malaysian patients with OSCC. Further, we did not find any association between p53 codon 72 polymorphism and HPV infection or between the p53 polymorphism and the risk of oral cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20419384     DOI: 10.1007/s00432-010-0886-8

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  51 in total

1.  Evaluation of polymerase chain reaction (PCR) method and hybrid capture II (HCII) assay for the detection of human papillomavirus in cervical scrapings.

Authors:  R Saini; T H Shen; N H Othman; J Santhanam; N Othman; T H Tang
Journal:  Med J Malaysia       Date:  2007-08

2.  Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India.

Authors:  J D'Costa; D Saranath; P Dedhia; V Sanghvi; A R Mehta
Journal:  Oral Oncol       Date:  1998-09       Impact factor: 5.337

3.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

4.  Telomerase activation and human papillomavirus infection in invasive uterine cervical carcinoma in a set of Malaysian patients.

Authors:  P L Cheah; L M Looi; M H Ng; V Sivanesaratnam
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

5.  p53 Polymorphism (codon-72) has no correlation with the development and the clinical features of cervical cancer.

Authors:  A. Nishikawa; T. Fujimoto; N. Akutagawa; M. Iwasaki; M. Takeuchi; K. Fujinaga; R. Kudo
Journal:  Int J Gynecol Cancer       Date:  2000-09       Impact factor: 3.437

6.  p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development.

Authors:  I Zehbe; G Voglino; E Wilander; H Delius; A Marongiu; L Edler; F Klimek; S Andersson; M Tommasino
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

7.  Human papillomavirus DNA in oral mucosal lesions.

Authors:  Lucia Giovannelli; Giuseppina Campisi; Anna Lama; Ornella Giambalvo; John Osborn; Valerio Margiotta; Pietro Ammatuna
Journal:  J Infect Dis       Date:  2002-02-20       Impact factor: 5.226

8.  P53 codon 72 polymorphism and correlation with ovarian and endometrial cancer in Greek women.

Authors:  T Agorastos; S Masouridou; A F Lambropoulos; S Chrisafi; D Miliaras; K Pantazis; T C Constantinides; A Kotsis; I Bontis
Journal:  Eur J Cancer Prev       Date:  2004-08       Impact factor: 2.497

Review 9.  Human papillomavirus (HPV) in head and neck cancer.

Authors:  Stina Syrjänen
Journal:  J Clin Virol       Date:  2005-03       Impact factor: 3.168

10.  Human papillomavirus DNA in oral squamous cell carcinomas and normal mucosa.

Authors:  C Ostwald; P Müller; M Barten; K Rutsatz; M Sonnenburg; K Milde-Langosch; T Löning
Journal:  J Oral Pathol Med       Date:  1994-05       Impact factor: 4.253

View more
  16 in total

1.  No significant association between p53 codon 72 Arg/Pro polymorphism and risk of oral cancer.

Authors:  Ning Jiang; Jie Pan; Lei Wang; Yin-Zhong Duan
Journal:  Tumour Biol       Date:  2012-11-29

2.  Prevalence of HPV in Oral Squamous Cell Carcinoma in South West India.

Authors:  Pooja Dalakoti; Balakrishnan Ramaswamy; Ajay M Bhandarkar; Dipak Ranjan Nayak; Sasidharanpillai Sabeena; Govindakarnavar Arunkumar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-08-21

Review 3.  The role of human papillomavirus in oral squamous cell carcinoma: myth and reality.

Authors:  Katinka Kansy; Oliver Thiele; Kolja Freier
Journal:  Oral Maxillofac Surg       Date:  2012-12-16

4.  High-risk human papillomavirus in the oral cavity of women with cervical cancer, and their children.

Authors:  Rajan Saini; Tan P Khim; Sarah A Rahman; Mazian Ismail; Thean H Tang
Journal:  Virol J       Date:  2010-06-16       Impact factor: 4.099

5.  HPV-16/18 detection does not affect the prognosis of head and neck squamous cell carcinoma in younger and older patients.

Authors:  Luciano Marques-Silva; Lucyana Conceição Farias; Carlos Alberto de Carvalho Fraga; Marcos Vinícius Macedo de Oliveira; Cláudio Marcelo Cardos; Thiago Fonseca-Silva; Carolina Cavalieri Gomes; Alfredo Maurício Batista De-Paula; Ricardo Santiago Gomez; André Luiz Sena Guimarães
Journal:  Oncol Lett       Date:  2012-02-01       Impact factor: 2.967

6.  P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility.

Authors:  Jun Hou; Ying Gu; Wei Hou; Song Wu; Yin Lou; Wenyu Yang; Ling Zhu; Yukun Hu; Ming Sun; Haowei Xue
Journal:  BMC Genet       Date:  2015-06-30       Impact factor: 2.797

7.  Detection of Human Papillomavirus 16-Specific IgG and IgM Antibodies in Patient Sera: A Potential Indicator of Oral Squamous Cell Carcinoma Risk Factor.

Authors:  Jesinda P Kerishnan; Subash C B Gopinath; Sia Bik Kai; Thean-Hock Tang; Helen Lee-Ching Ng; Zainal Ariff Abdul Rahman; Uda Hashim; Yeng Chen
Journal:  Int J Med Sci       Date:  2016-05-12       Impact factor: 3.738

8.  Knowledge about human papillomavirus (HPV) related oral cancers among oral health professionals in university setting-A cross sectional study.

Authors:  Shelly Arora; Srinivas Sulugodu Ramachandra; Christopher Squier
Journal:  J Oral Biol Craniofac Res       Date:  2017-12-05

9.  Association of Human Papilloma Virus 16 Infection and p53 Polymorphism among Tobacco using Oral Leukoplakia Patients: A Clinicopathologic and Genotypic Study.

Authors:  Seema Sikka; Pranav Sikka
Journal:  Int J Prev Med       Date:  2014-04

10.  Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis.

Authors:  Xian-Tao Zeng; Wei Luo; Pei-Liang Geng; Yi Guo; Yu-Ming Niu; Wei-Dong Leng
Journal:  BMC Cancer       Date:  2014-06-26       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.